RIPK3 and metabolic dysfunction-associated steatotic liver disease: In MCD (methionine and choline-deficient) diet-induced mouse model of NAFLD, RIPK3 deficiency reduces liver steatosis, liver inflammation and fibrosis, preventing liver injury [159].